Items where Author is "Ross, Joseph S."

Article

Zhang, Yichen, Chen, Dingyi, Fu, Mengyuan, Shi, Luwen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita K., Ross, Joseph S. and Guan, Xiaodong (2025) Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis. The Lancet Oncology, 26 (9). 1252 - 1260. ISSN 1470-2045

Naci, Huseyin ORCID: 0000-0002-7192-5751, Shahzad, Mahnum, Murphy, Peter, Zhang, Yichen, Costa, Rebecca, Ross, Joseph S. and Wagner, Anita K. (2025) Costs and benefits of early access to new cancer drugs through the U.S. Food and Drug Administration accelerated approval pathway. BMJ Medicine. ISSN 2754-0413 (In Press)

Zhang, Yichen, Chen, Dingyi, Fu, Mengyuan, Shi, Luwen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita Katharina, Ross, Joseph S. and Guan, Xiaodong (2025) Strength of evidence supporting cancer drug approvals in China, 2017-2021. Journal of Clinical Oncology, 43 (16_suppl). ISSN 0732-183X

Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2018) The US Food and Drug Administration’s expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements. Clinical Trials. ISSN 1740-7745

Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2018) The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation. Clinical Trials, 15 (3). pp. 243-246. ISSN 1740-7745